Is Thermo Fisher Scientific (TMO) Offering Value After Recent Share Price Weakness

Thermo Fisher Scientific (TMO) has experienced recent share price weakness, with a 7-day decline of 10.8% and a year-to-date decline of 20.7%, despite an 11.1% return over one year. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 22.5% at its current price of $469.71, with an intrinsic value estimated at $606.38 per share. Additionally, its P/E ratio of 25.49x is below the industry average and Simply Wall St’s proprietary “Fair Ratio” of 27.49x, further indicating undervaluation.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin